FI55343C - Foerfarande foer framstaellning av nya, blodtryckssaenkande 3-hydrazinopyrido(4,3-c)pyridazinderivat - Google Patents

Foerfarande foer framstaellning av nya, blodtryckssaenkande 3-hydrazinopyrido(4,3-c)pyridazinderivat

Info

Publication number
FI55343C
FI55343C FI1245/72A FI124572A FI55343C FI 55343 C FI55343 C FI 55343C FI 1245/72 A FI1245/72 A FI 1245/72A FI 124572 A FI124572 A FI 124572A FI 55343 C FI55343 C FI 55343C
Authority
FI
Finland
Prior art keywords
pyridazinderivat
hydrazinopyrido
blodtryckssaenkande
nya
foerfarande foer
Prior art date
Application number
FI1245/72A
Other languages
English (en)
Finnish (fi)
Other versions
FI55343B (fi
Inventor
Erhard Schenker
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH695271A external-priority patent/CH547808A/de
Priority claimed from CH695171A external-priority patent/CH547807A/de
Priority claimed from CH768371A external-priority patent/CH547814A/de
Priority claimed from CH767971A external-priority patent/CH547813A/de
Priority claimed from CH784871A external-priority patent/CH551433A/de
Priority claimed from CH784971A external-priority patent/CH553201A/de
Priority claimed from CH1512071A external-priority patent/CH555350A/de
Priority claimed from CH1512171A external-priority patent/CH555841A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of FI55343B publication Critical patent/FI55343B/fi
Publication of FI55343C publication Critical patent/FI55343C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI1245/72A 1971-05-11 1972-05-02 Foerfarande foer framstaellning av nya, blodtryckssaenkande 3-hydrazinopyrido(4,3-c)pyridazinderivat FI55343C (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CH695271A CH547808A (de) 1971-05-11 1971-05-11 Verfahren zur herstellung neuer cycloalkan(c)pyridazine.
CH695171A CH547807A (de) 1971-05-11 1971-05-11 Verfahren zur herstellung neuer cycloalkan(c)pyridazine.
CH768371A CH547814A (de) 1971-05-26 1971-05-26 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine.
CH767971A CH547813A (de) 1971-05-26 1971-05-26 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine.
CH784871A CH551433A (de) 1971-05-26 1971-05-28 Verfahren zur herstellung neuer 3-hydrazino-5,6,7,8-tetrahydropyrido (4,3-c)pyridazin-derivate.
CH784971A CH553201A (de) 1971-05-26 1971-05-28 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazinderivate.
CH1512071A CH555350A (de) 1971-05-26 1971-10-15 Verfahren zur herstellung neuer 3-hydrazinopyrido(4,3c)-pyridazine.
CH1512171A CH555841A (de) 1971-05-26 1971-10-15 Verfahren zur herstellung neuer 3-hydrazinopyrido-(4,3c)pyridazine.

Publications (2)

Publication Number Publication Date
FI55343B FI55343B (fi) 1979-03-30
FI55343C true FI55343C (fi) 1979-07-10

Family

ID=27570368

Family Applications (1)

Application Number Title Priority Date Filing Date
FI1245/72A FI55343C (fi) 1971-05-11 1972-05-02 Foerfarande foer framstaellning av nya, blodtryckssaenkande 3-hydrazinopyrido(4,3-c)pyridazinderivat

Country Status (16)

Country Link
US (2) US3838125A (fr)
JP (1) JPS5750791B1 (fr)
AU (1) AU472726B2 (fr)
BE (1) BE783219A (fr)
CA (1) CA943542A (fr)
DD (1) DD97418A5 (fr)
DK (1) DK139625B (fr)
FI (1) FI55343C (fr)
GB (2) GB1392474A (fr)
HU (1) HU168682B (fr)
IE (1) IE36710B1 (fr)
IL (1) IL39392A (fr)
NL (1) NL176565C (fr)
NO (1) NO136251C (fr)
PL (1) PL81827B1 (fr)
SE (1) SE400557B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO136251C (no) * 1971-05-11 1977-08-10 Sandoz Ag Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.
FI224574A (fr) * 1973-08-02 1975-02-03 Sandoz Ag
SE418800B (sv) * 1975-11-13 1981-06-29 Sandoz Ag Forfarande for framstellning av nya antihypertensiva preparat
US4277472A (en) * 1978-11-10 1981-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh 3,6-Disubstituted-5,7-(lower alkano)-5,6,7,8-tetrahydropyrido(4,3-C)pyridazines; their intermediates, preparation, antihypertensive use and compositions
US4473574A (en) * 1982-02-01 1984-09-25 Sandoz Ltd. Prophylaxis of arterial disease
US6176240B1 (en) 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6825196B2 (en) * 2002-03-05 2004-11-30 Barbeau Pharma, Inc. Stable pharmaceutical compositions
US6821974B2 (en) 2002-03-05 2004-11-23 Barbeau Pharma, Inc Stable pharmaceutical compositions
CN102911173A (zh) * 2012-11-08 2013-02-06 苏州施亚生物科技有限公司 5,6,7,8-四氢-2H-吡啶并[4,3-c]哒嗪-3-酮的合成方法
CN106905315B (zh) * 2017-03-02 2019-09-27 北京工业大学 四氢吡啶并[3,4-d]嘧啶类化合物及其制备方法和应用
EP3796372A4 (fr) 2018-07-10 2022-03-16 National Institute Of Advanced Industrial Science And Technology Structure stratifiée et son procédé de fabrication, et dispositif à semi-conducteur

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO136251C (no) * 1971-05-11 1977-08-10 Sandoz Ag Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.

Also Published As

Publication number Publication date
BE783219A (fr) 1972-11-09
NO136251C (no) 1977-08-10
NL7206477A (fr) 1972-11-14
NO136251B (fr) 1977-05-02
NL176565B (nl) 1984-12-03
IL39392A0 (en) 1972-07-26
GB1392475A (en) 1975-04-30
IL39392A (en) 1977-10-31
JPS5750791B1 (fr) 1982-10-28
US4478837A (en) 1984-10-23
NL176565C (nl) 1985-05-01
CA943542A (en) 1974-03-12
IE36710B1 (en) 1977-02-02
IE36710L (en) 1972-11-11
DD97418A5 (fr) 1973-05-05
AU472726B2 (en) 1976-06-03
HU168682B (fr) 1976-06-28
PL81827B1 (fr) 1975-10-31
AU4213572A (en) 1973-11-15
DK139625C (fr) 1979-09-03
GB1392474A (en) 1975-04-30
US3838125A (en) 1974-09-24
DK139625B (da) 1979-03-19
FI55343B (fi) 1979-03-30
SE400557B (sv) 1978-04-03

Similar Documents

Publication Publication Date Title
FI55186B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1,4-dihydropyridinkarboxylsyraestrar
CH554694A (de) Spielzeug-baustein.
NL7216836A (nl) Helikopter.
FI54299C (fi) Foerfarande foer framstaellning av saosom maskmedel verksamma 2-karbalkoxiaminobensimidazol-5(6)-fenyletrar
FI56115C (fi) Stabil haorfaergprodukt av olja- i vatten-emulsiontyp
FI55188B (fi) Foerfarande foer framstaellning av nya osymmetriska 1,4-dihydropyridindikarboxylsyraestrar
FI55146C (fi) Fordonsdaeck av typen radialdaeck
FI55343C (fi) Foerfarande foer framstaellning av nya, blodtryckssaenkande 3-hydrazinopyrido(4,3-c)pyridazinderivat
TR17828A (tr) 4-amino-1,2,4-triazin-5-onlarin imaline mahsus usul
BE789811A (fr) 1,4-bis-acylpiperazines
SE397349B (sv) Forfarande fer framstellning av nya 2,4 diamino-5-bensylpyrimidiner
FI56176B (fi) Foerfarande foer framstaellning av 2,4-diamino-5-bensylpyrimidiner
TR17956A (tr) 2,6-dinitroanilin herbisidler
FI55403B (fi) Anordning foer central uppvaermning av en lokal
NL177992C (nl) Hefschroefvliegtuig.
BE782530A (fr) 1,1-dialkyl-2-(indazolyl substitue-n1-methyl)hydrazines
FI56387B (fi) Foerfarande foer framstaellning av alkansulfonsyraestrar av 1,3,2-oxazafosforinfoereningar med immunitetssaenkande verkan
SU503826A1 (ru) Стекло
SE7601317L (sv) 1,4-bensodiazepin-2-onderivat
FI56533B (fi) Saett att framstaella nya 4alfa-karbamyloxi-8-alkoxi-10-metylen-3-metyl-2,9-dioxatricyklo(4,3,1,03,7)-dekaner
FI56373B (fi) Saosom mellanprodukter vid framstaellning av prostaglandiner eller prostaglandinliknande foereningar anvaendbara bicyklo(2,2,1)hept-2-en-7-syn-karbaldehyder
BE780846A (fr) 5-hydroxymethyl-(1,3-dioxa-2-sila-cylco-hexanes)
FI55190B (fi) Foerfarande foer framstaellning av terapeutiskt verksamma nya pikolinsyraderivat
FI56170B (fi) Nya, saosom mellanprodukter vid framstaellning av terapeutiskt vaerdefulla 3-indolylpiperidinderivat anvaendbara kvaternaera arylmetylpiperidiniumsalter
SE7514008L (sv) Nya fosinsylfider